Two workers at the Pharmasol manufacturing facility in Easton, Massachusetts, were injured when an aerosol can exploded and triggered a small fire last week.

Drug-delivery specialist Aptar Pharma is beefing up capacity at a New York plant to bring supplies of a key product closer to U.S. customers.

Manufacturing costs are a significant factor in pricing CAR-T cancer meds because of the intensive process required for the personalized treatments.

Dr. Reddy’s is recalling 765,058 cartons of its Zenatane acne med, which was manufactured for it by compatriot Cipla.

Women turning to Perrigo’s Option 2 emergency contraceptive may be facing more than one unexpected situation. Some boxes don’t contain the med.

Albany-New York based AMRI has agreed to a buyout worth more than $920 million as the M&A market for contract manufacturers continues to run hot.

Takeda is starting work on a €40 million plant to manufacture multiple myeloma drug Ninlaro at its site in Ireland, where it will add 40 new jobs.

Japan’s Sawai is following other drugmakers by establishing a U.S. manufacturing beachhead by acquiring a U.S. generics operation.